Feature | June 16, 2009

Covidien Warns Clients of Mo-99 Shortages



June 16, 2009 - In response to the molybdenum 99 (Mo-99) supply shortage, Covidien sent out a letter to its customers informing them of the anticipated Covidien generator and unit dose (UD) Tc 99m supply to the overall U.S., Canadian and Latin American markets through August 2009.


The update noted the National Research Universal (NRU) reactor in Chalk River, Canada, will be out of service for at least three months as reported by the Atomic Energy of Canada Ltd.; and the High Flux Reactor (HFR) in Petten, The Netherlands, has a planned shutdown in early July that is expected to last a few days.


Covidien has made arrangements through its diversified supply chain to the remaining online reactors in Belgium and South Africa, and have increased orders for Mo 99 from each reactor to partially offset the shortages caused by the HFR routine maintenance and ongoing NRU reactor shutdown.


Despite these efforts, the company expects there will still be a global shortage of Tc 99m generators during this period.


Covidien stated it should be able to supply its current customers, but not fully meet new demand coming from an influx of facilities seeking alternative suppliers of Mo-99. The company cautioned that at times it may not be able to fully meet even its current clients’ demand.


For more information: www.covidien.com


Related Content

Navidea, Mass General, Tc99m-tilmanocept, vulnerable plaque, cardiovascular disease, Harvard
News | Radiopharmaceuticals and Tracers| July 30, 2015
Navidea Biopharmaceuticals Inc. announced plans to move forward with a joint study of the ability of Tc99m-tilmanocept...
Medraysintell, nuclear medicine, World Market Report, radiopharmaceuticals
News | Nuclear Imaging| July 06, 2015
Medraysintell released its updated World Market Report and Directory on Nuclear Medicine, Edition 2015, in late June,...
GE Healthcare, FASTlab 2, FDG Duo, GENtrace cyclotron, PET imaging

FASTlab 2 with FDG Duo cassette image courtesy of GE Healthcare

Technology | June 08, 2015
GE Healthcare announced that it has created a solution to make positron emission tomography (PET) tracers for...
News | May 29, 2015
National Security Technologies LLC (NSTec) and Henderson, Nevada-based Global Medical Isotope Systems (GMIS) announced...
Mo-99, molybdenum, MURR, NorthStar, production, University of Missouri
News | May 07, 2015
NorthStar Medical Radioisotopes LLC has completed its first production-scale test run of the molybdenum-99 (Mo-99)...
Lantheus, flurpiridaz F 18, ICNC12, SPECT, CAD, PET, MPI, myocardial perfusion
News | May 04, 2015
Results from Lantheus Medical Imaging Inc.’s first Phase 3 study of flurpiridaz F 18 for myocardial perfusion imaging (...
NorthStar, RadioGenix, isotopes, separation system, Tc-99m

Image courtesy of NorthStar Medical Radioisotopes LLC

News | March 17, 2015
NorthStar Medical Radioisotopes LLC will unveil the commercial model of its RadioGenix isotope separation system during...
radiotherapeutics, nuclear medicine, PET, SPECT, MEDraysintell
News | March 10, 2015
The first annual financial results of Xofigo (radium-223 dichloride) from Bayer are in line with the MEDraysintell...
Pamela Woodard, nanoparticle, Washington University, PET scan, plaque

Pamela Woodard, M.D., led a team that designed a new imaging agent that may light up dangerous plaque in arteries.

Feature | January 30, 2015
The U.S. Food and Drug Administration (FDA) has approved for human evaluation a nanoparticle-based imaging agent...
News | November 13, 2014
Coquí RadioPharmaceuticals Corp. is working to become the first commercial producer of lifesaving medical isotopes in...
Overlay Init